SLC7A11 and cancer: Mechanically, radiotherapy can activate Ataxia-Telangiectasia mutated gene (ATM) to produce IFNγ and synergizes with immunotherapy-activated CD8+ T cells to suppress SLC7A11 expression in cancer cells.